Document is current
Any future updates will be listed below
-
Authors
Majchrzak-Stiller, B.
Buchholz, M.
Peters, I.
Strotmann, J.
Möhrke, J.
Zelichowski, L.
Oehlke, L.
Quensel, C.
Fein, D.
Höhn, P.
Müller, T.
Uhl, W.
Braumann, C.
-
Funding
Funding for this research was provided by:
Geistlich Pharma
Katholisches Klinikum Bochum gGmbh
- License Information
-
More Information
Article History
Received: 17 February 2023
Accepted: 15 April 2023
First Online: 12 May 2023
Declarations
:
: Thomas Müller is employed by Geistlich Pharma AG, Wolhusen, Switzerland. All other authors declare no conflict of interest. Geistlich Pharma AG, Wolhusen, Switzerland had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
: Not applicable.
